Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANTHER adjuvant chemotherapy trial in node-positive breast cancer
2007-002061-12Phase 3Completed
- Sponsor
- Austrian Breast and Colorectal Cancer Study Group
- Start
- Jul 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epirubicin, cyclophosphamide, docetaxel and fluorouracil in breast cancer (2 arms), sponsored by Austrian Breast and Colorectal Cancer Study Group. Primary endpoint: Breast cancer recurrence-free survival. Started Jul 2007; status: completed.
02
Drugs
epirubicincyclophosphamidedocetaxelfluorouracil
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2007-002061-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002061-12.